Ozempic is a gamechanger. Heres how it works.

which helps you feel fuller for longer.By mimicking the effects of GLP-1, semaglutide can also help you feel fuller for longer and reduce your appetite.

Ozempic is a drug approved by the FDA to manage type 2 diabetes. It has recently been in the news for its ability to help people lose weight. According to the latest data from the National Institutes of Health, 42% of adults in the US are currently categorized as obese. This is why Ozempic is such an important drug, as it helps people with diabetes manage their blood sugar levels, as well as aiding in weight loss.

Mila Clarke, a 33 year old with latent autoimmune diabetes in adults, runs a YouTube channel called Hangry Woman. She has documented her experience with Ozempic, and wishes people understood more about how difficult it is to live with both diabetes and obesity.

Ozempic works by mimicking the effects of GLP-1, a hormone released in the intestine when food enters the stomach. It has receptors in the pancreas that promote the production of insulin and suppress the production of glucagon, both of which help lower blood sugar levels. In the stomach, GLP-1 receptors slow gastric emptying and help people feel fuller for longer, reducing their appetite.

Overall, Ozempic is a safe and effective tool for weight loss, and has the potential to completely change the way we approach weight loss. GLP-1 based medications, like Semaglutide, help to slow the digestion of food, resulting in lower blood sugar spikes and a feeling of fullness for longer. This can be particularly beneficial for people living with obesity and type 2 diabetes, as it can help to suppress hunger cravings. Clinical trials have shown that Semaglutide can lead to an average weight reduction of around 15%, when paired with an adjusted diet and exercise routine, compared to a placebo group. Although there are side effects associated with these drugs, such as nausea and gastrointestinal effects, the number of prescriptions for Semaglutide has risen dramatically since becoming available in late 2017. In 2021, the FDA approved Semaglutide to be prescribed at a higher dose for weight management, branded under the name Wegovy.

However, it is important to remember that these drugs are not a ‘quick fix’ for obesity or diabetes, and it is still necessary to make healthy lifestyle choices in order to see the desired results. Furthermore, the drug is being trivialized and looked at as an ’easy weight loss solution’, which is unfortunate for people with diabetes and people living with obesity. Another medication, Mounjaro, is currently being fast tracked for approval by the FDA to be prescribed for weight loss too. Ultimately, these drugs can help to make managing diabetes a little easier and can help people think about diabetes less.